This patient presents with classic anaphylaxis — a Type I (IgE-mediated) hypersensitivity reaction with rapid onset urticaria, angioedema, bronchospasm, and hypotension following penicillin exposure. After acute management, the question asks for the most specific investigation to confirm IgE-mediated hypersensitivity.
| Feature | Intradermal Skin Test | Serum Penicillin-Specific IgE |
|---|---|---|
| Specificity | 90–95% (highest) | >90% |
| Sensitivity | 70–90% | 50–80% (lower) |
| Mechanism tested | Mast cell-bound IgE (in-vivo) | Circulating free IgE (in-vitro) |
| Gold standard status | Yes — per EAACI/AAAAI guidelines | Adjunct/alternative |
| Timing | Must defer 2–4 weeks post-acute reaction | Can be done sooner |
| Risk | Small anaphylaxis risk (performed by trained personnel) | No risk |
Clinical Pearl (per Roitt's Immunology and EAACI Drug Allergy Guidelines): Skin testing with penicillin determinants is the reference standard for diagnosing IgE-mediated penicillin allergy. Serum-specific IgE has lower sensitivity (50–80%) and may miss true allergy. The question asks for the most specific test — intradermal skin testing fulfills this criterion and is the accepted gold standard when performed 2–4 weeks after the acute event.
In Type I hypersensitivity, penicillin acts as a hapten, binding to serum proteins to form immunogenic conjugates. IgE antibodies are produced and bind to mast cell/basophil Fc receptors. Re-exposure cross-links surface IgE, triggering degranulation with release of histamine, tryptase, leukotrienes, and prostaglandins. Intradermal skin testing reproduces this local mast cell response, confirming sensitization.
Reference: Roitt's Immunology, 8th ed.; EAACI Drug Allergy Guidelines; Middleton's Allergy, 9th ed.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
Daily MCQs, study tips, and topper strategies on Telegram.
Join on Telegram →